Holen Sie sich die Stockscreener-App
18.27
4.76%
0.83
Handel nachbörslich:
18.34
0.07
+0.38%
Schlusskurs vom Vortag:
$17.44
Offen:
$17.5
24-Stunden-Volumen:
1.28M
Relative Volume:
0.57
Marktkapitalisierung:
$1.25B
Einnahmen:
$2.66B
Nettoeinkommen (Verlust:
$-1.21B
KGV:
-1.0253
EPS:
-17.82
Netto-Cashflow:
$-159.40M
1W Leistung:
+0.11%
1M Leistung:
+35.33%
6M Leistung:
-45.70%
1J Leistung:
-42.09%
1-Tages-Spanne:
$17.17
$18.57
1-Wochen-Bereich:
$15.49
$18.77
52-Wochen-Spanne:
$9.92
$35.58
Quidelortho Corp Stock (QDEL) Company Profile
Firmenname
Quidelortho Corp
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
18.27 | 1.25B | 2.66B | -1.21B | -159.40M | -17.82 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corp Aktie (QDEL) Neueste Nachrichten
QuidelOrtho (QDEL) Jefferies Global Healthcare Conference 2026 Summary - Quartr
QuidelOrtho Corp (QDEL) Shares Surge 4.8% -- What GF Score of 43 Tells Investors - GuruFocus
QuidelOrtho taps former Masimo executive Micah Young as CFO - MSN
QuidelOrtho (QDEL) Is Down 5.1% After Broad Russell Growth Index RemovalWhat's Changed - simplywall.st
Spotting Winners: QuidelOrtho (NASDAQ:QDEL) And Healthcare Equipment and Supplies Stocks In Q1 - Yahoo Finance
Neuberger Berman holds 3.53M shares of QuidelOrtho (QDEL) - Stock Titan
QuidelOrtho: Too Much Uncertainty Around Earnings Keeping Short-Interest Elevated (QDEL) - Seeking Alpha
Citi Maintains QuidelOrtho(QDEL.US) With Hold Rating, Raises Target Price to $18 - Moomoo
QuidelOrtho Corp highlights diagnostics portfolio as investors track Nasdaq listing - ad-hoc-news.de
QDEL stock eyes best day in over a year — point-of-care sale talks ignite rally - MSN
QuidelOrtho (QDEL) moves 32.2% higher: Will this strength last? - MSN
QuidelOrtho | 4: Statement of changes in beneficial ownership of securities-Officer Hanson Bryan Michael - Moomoo
QDELQuidelOrtho Corp Earnings - Finviz
QDEL Maintained by JP Morgan -- Price Target Raised to $12.00 - GuruFocus
J.P. Morgan Maintains QuidelOrtho(QDEL.US) With Sell Rating, Cuts Target Price to $12 - Moomoo
Is QuidelOrtho Corp (QDEL) a Bargain After 3.9% Drop? GF Value S - GuruFocus
Stocks making big moves yesterday: AppLovin, QuidelOrtho, Rocket Lab, Pinterest, and Zscaler - Barchart.com
QuidelOrtho (QDEL) Moves 32.2% Higher: Will This Strength Last? - Yahoo Finance
Does QuidelOrtho's (QDEL) Index Exit and New CFO Hint at a Shift in Growth Identity? - Yahoo Finance
QuidelOrtho (QDEL) stock trades up, here is why - MSN
Form 4 Quidel Corporation For: 29 June By Investing.com - Investing.com Canada
QuidelOrtho | 4: Statement of changes in beneficial ownership of securities-Director WIDDER KENNETH J - Moomoo
QuidelOrtho (QDEL) director receives 15,532 restricted stock units as equity award - Stock Titan
QuidelOrtho (QDEL) Stock Trades Up, Here Is Why - StockStory
Market Chatter: QuidelOrtho Weighs Sale of Point-of-Care Testing Business - Moomoo
Why is Quidel stock surging today? By Investing.com - Investing.com India
QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally - Stocktwits
QuidelOrtho (QDEL) Soars 33% Amid Sale Speculation - GuruFocus
QuidelOrtho (QDEL) to Sell Point-of-Care Testing Unit, Targeting $1.5 Billion Valuation - GuruFocus
Jefferies reiterates Quidel stock Hold rating on PoC business sale - Investing.com UK
Jefferies on QuidelOrtho (QDEL): 'we view a potential sale as a net positive' - StreetInsider
QuidelOrtho Corporation(NasdaqGS:QDEL) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
QuidelOrtho Corporation(NasdaqGS: QDEL) dropped from Russell 3000 Growth Benchmark - marketscreener.com
QuidelOrtho Corporation(NasdaqGS:QDEL) dropped from Russell 3000E Growth Benchmark - marketscreener.com
QuidelOrtho plans to sell testing unit for $1.5B: FT - MSN
QuidelOrtho (QDEL) Pursues $1.5B Sale of Testing Unit Amid Debt Reduction Efforts - GuruFocus
Diagnostics Firm QuidelOrtho Looks at Testing Unit Sale, Says FT - Bloomberg.com
QuidelOrtho looks to sell testing unit as PE circles healthcare companiesFT - TradingView
QuidelOrtho Corporation Actuals & Estimates (NASDAQ:QDEL) - TradingView
QuidelOrtho Corp (QDEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
QuidelOrtho Appoints Micah Young as Chief Financial Officer - Sahm
QuidelOrtho names Micah Young as chief financial officer - Investing.com UK
QuidelOrtho names Micah Young as chief financial officer By Investing.com - Investing.com South Africa
QuidelOrtho Names Micah Young Chief Financial Officer - citybiz
QuidelOrtho Appoints Micah Young Chief Financial Officer - marketscreener.com
Press Release: QuidelOrtho Appoints Micah Young as Chief Financial Officer - Moomoo
QDEL Technical Analysis & Stock Price Forecast - Intellectia AI
Finanzdaten der Quidelortho Corp-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Quidelortho Corp-Aktie (QDEL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Strobeck Matthew | Director |
Feb 13 '26 |
Buy |
23.96 |
10,000 |
239,586 |
27,775 |
| Busky Joseph M. | Chief Financial Officer |
Feb 13 '26 |
Buy |
23.66 |
3,370 |
79,742 |
10,290 |
| Blaser Brian J. | President and CEO |
Feb 13 '26 |
Buy |
23.59 |
10,540 |
248,661 |
40,073 |
| RHOADS ANN D | Director |
Dec 10 '25 |
Buy |
28.27 |
750 |
21,206 |
15,021 |
| Wilkins Joseph D Jr. | Director |
Nov 26 '25 |
Buy |
27.95 |
370 |
10,343 |
11,876 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Option Exercise |
15.74 |
7,021 |
110,511 |
41,087 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Sale |
27.81 |
4,026 |
111,965 |
37,061 |
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):